Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05044286 · ClinicalTrials.gov registry record
Longer-Acting PrEP in Transgender and Gender Diverse Texans
A clinical trial, sponsored by University of Texas at Austin.
- Completed
- Registry status
- 565
- Enrollment target
NCT05044286: Completed study, sponsored by University of Texas at Austin.
NCT05044286 is a clinical trial that has completed, run by University of Texas at Austin. The registered enrollment target is 565 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05044286 has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- 565 participants
- Enrollment target
Study Summary
The long-term goal of this project is to increase uptake and adherence of LA-PrEP in TGD populations in Texas. The central hypothesis is that strategies to increase uptake of LA- PrEP that are patient centered and understand the needs of TGD people will improve uptake and adherence. The objective of this observational study is to investigate barriers, facilitators, and preferences regarding willingness and intention to use LA-PrEP in TGD populations in Texas. Data from this study will support future research on patient centered strategies for uptake and adherence of LA-PrEP in TGD populations.
Primary Outcome
Participants will be asked how willing they are to use intramuscular injectable PrEP using a 6-point Likert scale ranging from "I would definitely not use intramuscular injectable PrEP" to I would definitely use intramuscular injectable PrEP."
Interventions
- OTHER no intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 565 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2023-08-31 |
What the finished NCT05044286 record still lists
NCT05044286 is an observational study that tracks outcomes without assigning an intervention. The registered 565 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which no intervention is the first listed.
NCT05044286 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05044286 about?
NCT05044286 is a clinical study titled "Longer-Acting PrEP in Transgender and Gender Diverse Texans". The long-term goal of this project is to increase uptake and adherence of LA-PrEP in TGD populations in Texas. The central hypothesis is that strategies to increase uptake of LA- PrEP that are patient centered and understand the needs of TGD people will improve uptake and adherence. The objective of...
What is the current status of trial NCT05044286?
This trial is currently completed. The enrollment target is 565 participants. The study started on 2022-02-01. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT05044286?
The interventions under investigation include: no intervention (OTHER).
Who is sponsoring clinical trial NCT05044286?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06146725 · 564 participants
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
- NCT06188520 · 564 participants · Phase 1
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
- NCT06628453 · 564 participants · NA
CGM for Management of Type 2 Diabetes in Pregnancy
- NCT07125326 · 564 participants · NA
How the Method of Bladder Emptying After Epidural Placement in Labor Affects Postpartum Voiding
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI